Chongqing Zhifei Biological Products Co., Ltd. (SHE:300122)
China
· Delayed Price · Currency is CNY 15.05
+0.12 (0.80%)
Apr 29, 2026, 3:13 PM CST
SHE:300122 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -14,807 | -14,745 | 2,018 | 8,070 | 7,539 | 10,209 | Upgrade
|
| Depreciation & Amortization | 515.29 | 515.29 | 385.01 | 323.71 | 314.94 | 375.85 | Upgrade
|
| Other Amortization | 19.17 | 19.17 | 19.75 | 14.68 | 15.89 | 13.01 | Upgrade
|
| Loss (Gain) From Sale of Assets | -5.88 | -5.88 | -0.05 | -41.37 | -0.01 | -0.04 | Upgrade
|
| Asset Writedown & Restructuring Costs | 13,633 | 13,633 | 0.36 | 0.13 | 0.09 | 1.68 | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.01 | -0.01 | - | - | - | 20.03 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | 609.27 | 352.59 | 420.87 | 190.74 | Upgrade
|
| Other Operating Activities | 838.1 | 829.95 | 187.57 | 394.49 | 166.06 | 134.48 | Upgrade
|
| Change in Accounts Receivable | 4,907 | 4,907 | 10,173 | -6,756 | -8,056 | -6,546 | Upgrade
|
| Change in Inventory | 3,622 | 3,622 | -13,254 | -1,313 | -765.61 | -3,982 | Upgrade
|
| Change in Accounts Payable | -868.54 | -868.54 | -4,180 | 8,338 | 2,413 | 8,064 | Upgrade
|
| Operating Cash Flow | 5,114 | 5,167 | -4,414 | 8,996 | 1,989 | 8,508 | Upgrade
|
| Operating Cash Flow Growth | 1242.69% | - | - | 352.30% | -76.62% | 143.30% | Upgrade
|
| Capital Expenditures | -513.78 | -619.19 | -930.34 | -1,134 | -1,453 | -1,932 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.6 | 6.94 | 4.76 | 168.07 | 0.65 | 0.32 | Upgrade
|
| Investment in Securities | 1.65 | 5.65 | - | -10.5 | -45.5 | -69 | Upgrade
|
| Other Investing Activities | 10.65 | 11.65 | - | - | - | -18.55 | Upgrade
|
| Investing Cash Flow | -500.89 | -594.94 | -925.58 | -976.6 | -1,498 | -2,019 | Upgrade
|
| Short-Term Debt Issued | - | - | 1.16 | 5.54 | 39.08 | 94.63 | Upgrade
|
| Long-Term Debt Issued | - | 13,348 | 14,738 | 6,342 | 5,477 | 2,569 | Upgrade
|
| Total Debt Issued | 15,349 | 13,348 | 14,739 | 6,348 | 5,517 | 2,663 | Upgrade
|
| Short-Term Debt Repaid | - | - | -1.55 | -0.39 | -18.64 | -75.01 | Upgrade
|
| Long-Term Debt Repaid | - | -17,641 | -10,199 | -9,739 | -6,643 | -5,312 | Upgrade
|
| Total Debt Repaid | -20,904 | -17,641 | -10,200 | -9,739 | -6,661 | -5,387 | Upgrade
|
| Net Debt Issued (Repaid) | -5,555 | -4,293 | 4,539 | -3,391 | -1,145 | -2,723 | Upgrade
|
| Repurchase of Common Stock | - | - | -300.03 | - | - | - | Upgrade
|
| Common Dividends Paid | -388.46 | -344.81 | -2,528 | -889.29 | -1,015 | -861.96 | Upgrade
|
| Other Financing Activities | -98.65 | -95.02 | -13.52 | -13.08 | -12.82 | -4.76 | Upgrade
|
| Financing Cash Flow | -6,042 | -4,733 | 1,698 | -4,294 | -2,173 | -3,590 | Upgrade
|
| Foreign Exchange Rate Adjustments | -17.48 | -0.69 | 1.25 | -2.3 | 17.56 | -9.66 | Upgrade
|
| Net Cash Flow | -1,446 | -161.11 | -3,640 | 3,724 | -1,664 | 2,889 | Upgrade
|
| Free Cash Flow | 4,600 | 4,548 | -5,344 | 7,862 | 535.93 | 6,575 | Upgrade
|
| Free Cash Flow Growth | - | - | - | 1367.02% | -91.85% | 146.30% | Upgrade
|
| Free Cash Flow Margin | 52.54% | 50.77% | -20.50% | 14.86% | 1.40% | 21.45% | Upgrade
|
| Free Cash Flow Per Share | 1.92 | 1.90 | -2.23 | 3.28 | 0.22 | 2.74 | Upgrade
|
| Cash Income Tax Paid | 442.4 | 443.94 | 2,070 | 3,310 | 3,274 | 1,955 | Upgrade
|
| Levered Free Cash Flow | 19,394 | 16,815 | -10,534 | 1,494 | -3,931 | 2,887 | Upgrade
|
| Unlevered Free Cash Flow | 19,394 | 16,815 | -10,442 | 1,545 | -3,898 | 2,922 | Upgrade
|
| Change in Working Capital | 4,921 | 4,921 | -7,634 | -117.72 | -6,468 | -2,437 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.